Clinical trial Recruiting at 7 sites Phase 2 Interventional Ages 5 to 18

Oxygen therapy for children with Down Syndrome and sleep apnea

Official title: Randomized Control Trial of Oxygen Therapy in Children and Adolescents With Down Syndrome and Obstructive Sleep Apnea

Run by Brigham and Women's Hospital · NCT06043440 · Data updated 2026-11-12

This study is testing whether giving extra oxygen during sleep can help improve thinking skills and overall health in children with Down Syndrome who have sleep apnea.

More Down Syndrome trials

Quick facts

PhasePhase 2
Study typeInterventional
Ages5 Years to 18 Years
SexAll
Enrollment230 (estimated)
SponsorBrigham and Women's Hospital
Academic / other
Locations7 sites (Los Angeles, California and 6 other locations)
StatusRecruiting
StartedOctober 24, 2023
Main results expectedNovember 30, 2027
Study endsDecember 30, 2027
Registry record updatedSeptember 30, 2026
Trial IDNCT06043440 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 5 to 17.9 years with moderate to severe obstructive sleep apnea and a favorable response to oxygen therapy.

Probably not a fit

Patients who have clinically significant hypoxia or those who have already undergone adenotonsillectomy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effects of oxygen supplementation during sleep on cognitive function and other health outcomes in children with Down Syndrome who have moderate to severe Obstructive Sleep Apnea. It is a randomized, single-blind study lasting six months, where participants will undergo various assessments including polysomnography, neurocognitive testing, and echocardiography. The study will recruit children from sleep clinics, Down syndrome clinics, and local associations, focusing on those who have not responded to standard treatments like adenotonsillectomy.

Why it matters

Potential benefit: If successful, this study could enhance cognitive function and overall quality of life for children with Down Syndrome suffering from sleep apnea.

How similar studies have gone: Other studies have explored oxygen therapy in similar contexts, but this specific approach in children with Down Syndrome and sleep apnea is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Ages 5.0 to 17.9 years at the time of screening
2. Children with OSA and obstructive apnea hypopnea index (OAHI) ≥5/hour.
3. Absence of clinically significant hypoxia defined as oxygen saturation \<88% for 5 minutes or episodic desaturation to 60% as these levels would otherwise identify children eligible to routinely receive oxygen.
4. Favorable response to oxygen therapy (allowing randomization) will be defined as follows:

   1. Oxygen saturation nadir \>92% and
   2. Decrease in obstructive index \< 5 / hour or by \> 50% from screening PSG
   3. Reaching an optimum oxygen flow which is defined as the flow that achieves the lowest level of AHI with maximum CO2 level less than 65 mmHg observed for 5 consecutive minutes and or an increase in CO2 by less than 15 points above baseline. The above criteria are observed while the patient spends a minimal of 30 minutes in the supine position and at least one cycle of rapid eye movement (REM) sleep.
   4. Oxygen flow required does not exceed 3.0 LPM and does not exceed a FiO2 \> 40 %.
5. Willingness to comply with all study procedures and available for duration of study.
6. At baseline the participant attempts to perform the neuropsychological tests

Exclusion Criteria:

1. Current CPAP use with documented compliance(\> 4 hrs/ night; \> 70% of nights).
2. Oxygen saturation \< 90% at rest during wakefulness.
3. Chronic daytime or nighttime use of supplemental oxygen.
4. Smoker in the child's bedroom.
5. Unrepaired congenital heart disease.
6. Moderate to severe pulmonary hypertension requiring treatment with oxygen and or pulmonary vasodilator.
7. Unable to participate in a PSG.
8. Individuals who develop alveolar hypoventilation with oxygen as previously defined.
9. Other severe chronic diseases determined by their provider as making them poor study candidates.
10. Enrolled or planning to enroll in another study that may conflict with protocol requirements or confound results in this trial.
11. Documented clinically significant untreated hypothyroidism
12. Children with adenotonsillar hypertrophy who are candidates for adenotonsillectomy and parents agree to the surgery.

Where it's running

  • Children's Hospital of Los Angeles
    Los Angeles, California, United States
    Recruiting
  • University of Michigan, Ann Arbor Hospital
    Ann Arbor, Michigan, United States
    Recruiting
  • Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio, United States
    Recruiting
  • Rainbow Babies and Children's Hospital, Case Medical Center
    Cleveland, Ohio, United States
    Recruiting
  • Children's Hospital of Philadelphia
    Philadelphia, Pennsylvania, United States
    Recruiting
  • East Virginia Medical Center
    Norfolk, Virginia, United States
    Recruiting
Show 1 more location
  • Seattle Children's Hospital
    Seattle, Washington, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.